Intensive-care-unit-acquired bloodstream infections in a regional critically ill population

Journal of Hospital Infection

Volumn 58, Issue 2, 2004, Pages 137-145

  Laupland, Kevin B ^a   Kirkpatrick, A W ^a   Church, D L ^a   Ross, T ^a   Gregson, D B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Bacteraemia; Bloodstream infection; Intensive care unit; Mortality; Nosocomial infection

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CANADA; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIAGNOSTIC PROCEDURE; DYING; ENTEROCOCCUS FAECALIS; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; INJURY; INTENSIVE CARE UNIT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MICROBIOLOGY; MORTALITY; NEUROSURGERY; NONHUMAN; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; SURGICAL TECHNIQUE;

ADULT; AGED; ALBERTA; APACHE; BACTEREMIA; BACTERIA, ANAEROBIC; CANDIDA; COHORT STUDIES; CRITICAL ILLNESS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PATIENT ADMISSION; RISK FACTORS;

EID: 4844219633     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2004.06.007     Document Type: Article

References (36)

1. Laupland K.B. Zygun D.A. Davies H.D. Church D.L. Louie T.J. Doig C.J. Population-based assessment of intensive care unit-acquired bloodstream infections in adults: incidence, risk factors, and associated mortality rate Crit Care Med 30 2002 2462-2467
2. Rello J. Ricart M. Mirelis B. et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes Intens Care Med 20 1994 94-98
3. Pittet D. Thievent B. Wenzel R.P. Li N. Auckenthaler R. Suter P. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients Am J Respir Crit Care Med 153 1996 684-693
4. Pittet D. Tarara D. Wenzel R.P. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598-1601
5. Garrouste-Orgeas M. Chevret S. Mainardi J.L. Timsit J.F. Misset B. Carlet J. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome J Hosp Infect 44 2000 206-213
6. Vosylius S. Sipylaite J. Ivaskevicius J. Intensive care unit acquired infection: a prevalence and impact on morbidity and mortality Acta Anaesthesiol Scand 47 2003 1132-1137
7. Rosenthal V.D. Guzman S. Orellano P.W. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay Am J Infect Control 31 2003 291-295
8. Erbay H. Yalcin A.N. Serin S. et al. Nosocomial infections in intensive care unit in a Turkish university hospital: a 2-year survey Intens Care Med 29 2003 1482-1488
9. Valles J. Leon C. Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC) Clin Infect Dis 24 1997 387-395
10. Digiovine B. Chenoweth C. Watts C. Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit Am J Respir Crit Care Med 160 1999 976-981
11. Dimick J.B. Pelz R.K. Consunji R. Swoboda S.M. Hendrix C.W. Lipsett P.A. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit Arch Surg 136 2001 229-234
12. Rello J. Ochagavia A. Sabanes E. et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients Am J Respir Crit Care Med 162 2000 1027-1030
13. Laupland K.B. Church D.L. Mucenski M. Sutherland L.R. Davies H.D. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections J Infect Dis 187 2003 1452-1459
14. Davies H.D. McGeer A. Schwartz B. et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group N Engl J Med 335 1996 547-554
15. Doig C.J. Zygun D.A. Fick G.H. et al. Study of clinical course of organ dysfunction in intensive care Crit Care Med 32 2004 384-390
16. Roberts F.J. Definition of polymicrobial bacteremia Rev Infect Dis 11 1989 1029-1030
17. Costel E.E. Mitchell S. Kaiser A.B. Abbreviated surveillance of nosocomial urinary tract infections: a new approach Infect Control 6 1985 11-13
18. Knaus W. Draper E. Wagner D. Zimmerman J. APACHE II: a severity of disease classification system Crit Care Med 13 1985 818-829
19. Cullen D. Civetta J. Briggs B. Ferrara L. Therapeutic interventions scoring system: a method of quantitative comparison of patient care Crit Care Med 2 1974 57-60
20. Vincent J.L. Bihari D.J. Suter P.M. et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee JAMA 274 1995 639-644
21. Rosenberg A.L. Hofer T.P. Strachan C. Watts C.M. Hayward R.A. Accepting critically ill transfer patients: adverse effect on a referral center's outcome and benchmark measures Ann Intern Med 138 2003 882-890
22. Kokmen E. Ozsarfati Y. Beard C.M. O'Brien P.C. Rocca W.A. Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease J Clin Epidemiol 49 1996 79-83
23. Paltiel O. Ronen I. Polliack A. Epstein L. Two-way referral bias: evidence from a clinical audit of lymphoma in a teaching hospital J Clin Epidemiol 51 1998 93-98
24. Warner M.A. Hosking M.P. Lobdell C.M. Offord K.P. Melton L.J.3rd Effects of referral bias on surgical outcomes: a population-based study of surgical patients 90 years of age or older Mayo Clin Proc 65 1990 1185-1191
25. Laupland K.B. Gregson D.B. Zygun D.A. Doig C.J. Mortis G. Church D.L. Severe bloodstream infections: a population-based assessment Crit Care Med 32 2004 992-997
26. Richards M.J. Edwards J.R. Culver D.H. Gaynes R.P. Nosocomial infections in combined medical-surgical intensive care units in the United States Infect Control Hosp Epidemiol 21 2000 510-515
27. Laupland K.B. Church D.L. Gregson D.B. Evaluation of a rapid bacterial ATP assay for screening BAL samples from ICU patients submitted for quantitative bacterial cultures Diagn Microbiol Infect Dis 47 2003 465-469
28. Laupland K.B. Zygun D.A. Davies H.D. Church D.L. Louie T.J. Doig C.J. Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill J Crit Care 17 2002 50-57
29. Eggimann P. Pittet D. Infection control in the ICU Chest 120 2001 2059-2093
30. van Nieuwenhoven C.A. Buskens E. van Tiel F.H. Bonten M.J. Relationship between methodological trial quality and the effects of selective digestive decontamination on pneumonia and mortality in critically ill patients JAMA 286 2001 335-340
31. Stoutenbeek C.P. Van Saene H.K. Miranda D.R. Zandstra D.F. A new technique of infection prevention in the intensive care unit by selective decontamination of the digestive tract Acta Anaesthesiol Belg 34 1983 209-221
32. de Jonge E. Schultz M.J. Spanjaard L. et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial Lancet 362 2003 1011-1016
33. Sun X. Wagner D.P. Knaus W.A. Does selective decontamination of the digestive tract reduce mortality for severely ill patients? Crit Care Med 24 1996 753-755
34. Kollef M.H. Opinion: the clinical use of selective digestive decontamination Crit Care 4 2000 327-332
35. Perl T.M. Cullen J.J. Wenzel R.P. et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections N Engl J Med 346 2002 1871-1877
36. Laupland K.B. Conly J.M. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review Clin Infect Dis 37 2003 933-938